In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso

BACKGROUND: Artemisinin-based combination therapy (ACT) is recommended to improve malaria treatment efficacy and limit drug-resistant parasites selection in malaria endemic areas. 5 years after they were adopted, the efficacy and safety of artemether–lumefantrine (AL) and artesunate–amodiaquine (ASA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Malar J
Hlavní autoři: Lingani, Moussa, Bonkian, Léa Nadège, Yerbanga, Isidore, Kazienga, Adama, Valéa, Innocent, Sorgho, Hermann, Ouédraogo, Jean Bosco, Mens, Petronella Francisca, Schallig, Henk D. F. H., Ravinetto, Raffaella, d’Alessandro, Umberto, Tinto, Halidou
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945612/
https://ncbi.nlm.nih.gov/pubmed/31906948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-019-3089-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky